MedTrace Logo

Autologous Platelet-Rich Plasma (PRP) and Endometrial Thickness

NCT03067623 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2019-05-23

No results posted yet for this study

Summary

The goal of this interventional study is to evaluate the increasing in endometrial thickening after the intrauterine infusion of 0,5-1 ml of autologous Platelet-Rich Plasma (PRP) and the implantation rate in women with thin endometrium undergoing Embryo-transfer, in order to propose a novel therapeutic approach for women with an endometrium \< 7 mm unresponsive to standard treatments.

Conditions

  • Thin Endometrium
  • Endometrial Disorder
  • Endometrial Thickness Not Growing Under Estrogen Stimulation

Interventions

DRUG

PRP

PRP intrauterine infusion

DEVICE

Tomcat catheter

PRP intrauterine infusion by means Tomcat catheter

Sponsors & Collaborators

  • University Magna Graecia

    lead OTHER

Principal Investigators

  • Roberta Venturella, MD · Magna Graecia University of Catanzaro

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
46 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-02-27
Primary Completion
2019-12-31
Completion
2020-02-27

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03067623 on ClinicalTrials.gov